06-Nov-2026 10:20:44
SYMBIOTEC PHARMALAB: SIGNS 10-YEAR TAKE-OR-PAY AGREEMENT FOR ALTERNATIVE PROTEIN MANUFACTURING
• Long-Term Agreement: Signed a 10-year take-or-pay manufacturing agreement with a European alternative protein innovator • Business Diversification: Expanding into fermentation-based alternative protein manufacturing • Manufacturing Partnership: Agreement covers production of alternative proteins using fermentation technology • Revenue Visibility: Take-or-pay structure could provide greater long-term demand and revenue predictability, subject to contract terms • Manufacturing Capabilities: Plans to leverage existing fermentation expertise and manufacturing infrastructure • Global Opportunity: Partnership supports expansion into the international alternative protein market • Growth Strategy: Diversifies manufacturing opportunities beyond the company's existing pharmaceutical business • Contract Value: Financial consideration and expected annual revenue contribution are not clearly disclosed in the supplied screenshot
SYMBIOTEC PHARMALAB LTD